Revise unfair trade practices and consumer protections involving prescription drugs under the federal 340B program

LC 578 aimed to revise unfair pricing practices and strengthen consumer protections for prescription drugs under the federal 340B program, which requires drug manufacturers to provide discounted drugs to safety-net hospitals and clinics. The bill sought to update rules governing how these discounts are applied and ensure patients receive clearer protections against deceptive pricing. It directly affected covered entities like community health centers and their patients by targeting alleged unfair trade practices within the 340B program. The bill was introduced but died in committee on May 22, 2025, without becoming law.